It's getting a bit repetitive. The call (battle cry) for repeal, waivers or at least a delay in health reform is everywhere in the health insurance industry. It's also coming from retailers, pharmacies and manufacturers.
Last week, opposition resonated from a number of groups that want Congress to change the new federal law, effective Jan. 1, and allow over-the-counter drugs to be purchased with money from flexible spending accounts.
These groups are asking Congress — during its lame duck session — to push back the law's start date two years, if it won't repeal altogether.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
